Immatics N.V. (IMTX) is a biological products, (no diagnostic substances) company incorporated in Netherlands, listed on the Nasdaq. With a market capitalization of $1.3 billion, Immatics N.V. is a small-cap company. The stock currently trades at $9.99, down 3.38% today, with a 52-week range of $3.30–$12.41.
No 10-K filings found.